Search results
Avadel Pharmaceuticals Reports First Quarter 2024 Earnings: Reve
Guru Focus· 7 hours agoOn May 8, 2024, Avadel Pharmaceuticals PLC (AVDL, Financial) released its 8-K filing, announcing its financial results for the first quarter ended March 31, 2024. The specialty pharmaceutical ...
The 7 Top-Selling Cannabis Companies Ranked by Revenue: Which Weed Stocks to Buy?
InvestorPlace· 4 hours agoWhispers and rumors of widespread cannabis legalization are growing louder. Although the last major...
Axsome (AXSM) Q1 Loss Widens Y/Y, Revenues Beat Estimates
Zacks via Yahoo Finance· 1 day agoThe figure beat our model estimate of $68.6 million. Product revenues in the first quarter benefited...
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoAxsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2024 Earnings Call Transcript May 6, 2024 Axsome...
Wellbutrin vs Adderall: Important Differences You Should Know
MediaFeed via AOL· 12 hours agoAnxiety and depression are two common mental conditions — it’s estimated that about 40 million...
A little-understood sleep disorder affects millions and has clear links to dementia – 4 questions...
The Conversation via Yahoo News· 3 days agoThe disease mechanism is not well understood. In some cases of REM sleep behavior disorder, a clear...
Alkermes' (ALKS) Q1 Earnings & Revenues Fall Shy of Estimates
Zacks via Yahoo Finance· 6 days agoRecent Updates Last month, Alkermes announced positive top-line data from a phase Ib study...
Earnings call: Axsome Therapeutics sees robust growth in Q1 2024 By Investing.com
Investing.com· 2 days agoAxsome Therapeutics (NASDAQ: NASDAQ:AXSM) reported a significant year-over-year revenue increase of...
The Bruins’ survival, the Maple Leafs’ heartbreak, and other final thoughts from an absurd...
The Boston Globe· 3 days agoTied at 1-1 entering OT Saturday night, the Leafs chose an inopportune time for their five skaters...
Jazz (JAZZ) Q1 Earnings & Sales Fall Short of Estimates
Zacks via Yahoo Finance· 6 days agoXywav, a low-sodium formulation of Xyrem, recorded sales of $315.3 million in the quarter, up 14%...